Republican Scientific and Practical Centre of Pulmonology and Tuberculosis

Recent papers from Republican Scientific and Practical Centre of Pulmonology and Tuberculosis

1. Tracheal diverticulum: clinical features, diagnosis, and surgical treatmentPirogov Russian Journal of Surgery · 2026
2. Cost-effectiveness of BPaL-based and 9-month modified all-oral short treatment regimens for rifampicin-resistant tuberculosis in BelarusPLOS Global Public Health · 2026
3. Characteristics, treatment strategies, and long-term health outcomes of people with bedaquiline-resistant tuberculosis in Karakalpakstan, Uzbekistan – a retrospective cohort studyOpen Forum Infectious Diseases · 2026
4. Pharmacokinetics, bactericidal activity and toxicity of short oral regimens for rifampicin-resistant tuberculosis treatmentNature Communications · 2026
5. Sequence-encoded determinants of regional mutational plasticity: comparative analysis of PE_PGRS genes in Mycobacterium tuberculosis and other bacteria.2026
6. Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant tuberculosis patientsScientific Reports · 2026
7. HIV/TB in BelarusEuropean Respiratory Journal · 2011
8. Drug-resistant tuberculosis in war and complex emergencies: jeopardising progress towards TB elimination and antimicrobial resistance control – a scoping review and perspectiveBMJ Global Health · 2026
9. Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherenceAmerican Journal of Epidemiology · 2026
10. Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant Tuberculosis patients2025
11. Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of MoldovaBMJ Global Health · 2025
12. Оценка Клинической Тяжести Взрослых Пациентов С МуковисцидозомHealth and Ecology Issues · 2014
13. Prediction of the course of chronic obstructive pulmonary disease by blood biomarkersBiomeditsinskaya Khimiya · 2025
14. Implementing standardised community-based service package to improve TB outcomes in six countriesPublic Health Action · 2025
15. CD206 and dust particles are prognostic biomarkers of progressive fibrosing interstitial lung disease associated with air pollutant exposureScientific Reports · 2025
16. Efficacy and safety of treatment of HIV-associated multidrug-resistant tuberculosis. Systematic review and meta-analysisJournal Infectology · 2025
17. Perspectives on multisectoral accountability framework to end tuberculosis in the Eastern Europe and Central Asia region: a mixed-methods studyBMC Global and Public Health · 2025
18. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and UzbekistanClinical Infectious Diseases · 2025
19. Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in EuropeSHILAP Revista de lepidopterología · 2025
20. 24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluationThe Lancet Global Health · 2025